Skip to main content

Table 4 Other outcomes in the HFNC and NIV groups

From: High-flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease patients after extubation: a multicenter, randomized controlled trial

 

HFNC (n = 44)

NIV (n = 42)

p value

Duration of HFNC or NIV, hours

83.9 ± 33.1

70.9 ± 30.6

0.063

Airway care interventions, per day

6 (4–7)

7 (5–9.3)

0.006

Comfort score

7 (6–8)

5 (4–7)

0.000

Dyspnea score

3 (2–4)

2 (2–3)

0.136

Nasal facial skin breakdown, n (%)

0 (0)

5 (9.6)

0.027

Length of stay in ICU, days

7.5 (6–10)

8.5 (6–12.3)

0.324

Length of stay in hospital, days

10 (8.3–12)

11 (9–14.3)

0.245

28-day mortality, n (%)

7 (15.9)

5 (11.9)

0.758

  1. Data are shown as means ± standard deviation, number (%) patients, or median (interquartile range)
  2. HFNC high-flow nasal cannula oxygen therapy, NIV non-invasive ventilation, ICU intensive care unit